• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素受体亚型 5(SST)在垂体和胰腺神经内分泌肿瘤中的表观遗传和转录后调控。

Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST ) in pituitary and pancreatic neuroendocrine tumors.

机构信息

Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain.

Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain.

出版信息

Mol Oncol. 2022 Feb;16(3):764-779. doi: 10.1002/1878-0261.13107. Epub 2021 Oct 26.

DOI:10.1002/1878-0261.13107
PMID:34601790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8807362/
Abstract

Somatostatin receptor subtype 5 (SST ) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is poorly understood. Recently, an overlapping natural antisense transcript, SSTR5-AS1, potentially regulating SSTR5 expression, was identified. We aimed to elucidate whether epigenetic processes contribute to the regulation of SSTR5 expression in PitNETs (somatotropinomas) and PanNETs. We analyzed the SSTR5/SSTR5-AS1 human locus in silico to identify CpG islands. SSTR5 and SSTR5-AS1 expression was assessed by quantitative real-time PCR (qPCR) in 27 somatotropinomas, 11 normal pituitaries (NPs), and 15 PanNETs/paired adjacent (control) samples. We evaluated methylation grade in four CpG islands in the SSTR5/SSTR5-AS1 genes. Results revealed that SSTR5 and SSTR5-AS1 were directly correlated in NP, somatotropinoma, and PanNET samples. Interestingly, selected CpG islands were differentially methylated in somatotropinomas compared with NPs. In PanNETs cell lines, SSTR5-AS1 silencing downregulated SSTR5 expression, altered aggressiveness features, and influenced pasireotide response. These results provide evidence that SSTR5 expression in PitNETs and PanNETs can be epigenetically regulated by the SSTR5-AS1 antisense transcript and, indirectly, by DNA methylation, which may thereby impact tumor behavior and treatment response.

摘要

生长抑素受体亚型 5(SST)是垂体(PitNETs)和胰腺(PanNETs)神经内分泌肿瘤的新兴生物标志物和可操作靶点。SSTR5 基因表达和 mRNA 生物发生的转录和表观遗传调控知之甚少。最近,发现了一种重叠的天然反义转录本 SSTR5-AS1,它可能调节 SSTR5 的表达。我们旨在阐明表观遗传过程是否有助于调节 PitNETs(生长激素瘤)和 PanNETs 中的 SSTR5 表达。我们通过定量实时 PCR(qPCR)在 27 例生长激素瘤、11 例正常垂体(NPs)和 15 例 PanNETs/配对相邻(对照)样本中分析了 SSTR5/SSTR5-AS1 人基因座,以鉴定 CpG 岛。我们评估了 SSTR5/SSTR5-AS1 基因中四个 CpG 岛的甲基化程度。结果表明,在 NP、生长激素瘤和 PanNET 样本中 SSTR5 和 SSTR5-AS1 直接相关。有趣的是,与 NPs 相比,选定的 CpG 岛在生长激素瘤中存在差异甲基化。在 PanNET 细胞系中,SSTR5-AS1 沉默下调 SSTR5 表达,改变侵袭性特征,并影响培高利特反应。这些结果表明,PitNETs 和 PanNETs 中的 SSTR5 表达可以通过 SSTR5-AS1 反义转录本的表观遗传调控,以及间接通过 DNA 甲基化来调控,这可能影响肿瘤行为和治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/a5fac0b16e6e/MOL2-16-764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/5ae46d0909ee/MOL2-16-764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/e9d2965c220f/MOL2-16-764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/b8ed8c74e29b/MOL2-16-764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/a5fac0b16e6e/MOL2-16-764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/5ae46d0909ee/MOL2-16-764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/e9d2965c220f/MOL2-16-764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/b8ed8c74e29b/MOL2-16-764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/947c/8807362/a5fac0b16e6e/MOL2-16-764-g001.jpg

相似文献

1
Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST ) in pituitary and pancreatic neuroendocrine tumors.生长抑素受体亚型 5(SST)在垂体和胰腺神经内分泌肿瘤中的表观遗传和转录后调控。
Mol Oncol. 2022 Feb;16(3):764-779. doi: 10.1002/1878-0261.13107. Epub 2021 Oct 26.
2
Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.异常甲基化介导的长链非编码 RNA SSTR5-AS1 下调促进喉鳞状细胞癌的进展和转移。
Epigenetics Chromatin. 2019 Jun 13;12(1):35. doi: 10.1186/s13072-019-0283-8.
3
Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.生长抑素受体5型(SSTR5)信使核糖核酸表达与胰岛素瘤细胞增殖的组织病理学特征相关。
Endocr Relat Cancer. 2006 Mar;13(1):69-78. doi: 10.1677/erc.1.00962.
4
Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.生长激素瘤和无功能垂体腺瘤中生长抑素受体亚型(SSTR1 - 5)基因表达水平的定量分析。
Eur J Endocrinol. 2007 Jan;156(1):65-74. doi: 10.1530/eje.1.02313.
5
Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.神经内分泌肺癌患者外周血中生长抑素受体亚型 SSTR2a、SSTR3 和 SSTR5 的基因表达。
Cell Oncol (Dordr). 2011 Oct;34(5):435-41. doi: 10.1007/s13402-011-0025-9. Epub 2011 Apr 19.
6
DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.肿瘤抑制基因在垂体神经内分泌肿瘤中的甲基化。
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1272-1282. doi: 10.1210/jc.2018-01856.
7
Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.采用定量 PCR 技术对生长抑素受体亚型表达谱进行分析,并与胰腺内分泌肿瘤的临床病理特征相关性研究。
Pancreas. 2010 Nov;39(8):1147-54. doi: 10.1097/MPA.0b013e3181e78120.
8
DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.生长激素细胞垂体神经内分泌肿瘤中的 DNA 甲基化模式。
Neuroendocrinology. 2024;114(1):51-63. doi: 10.1159/000533692. Epub 2023 Sep 12.
9
ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.ZAC1 和 SSTR2 在无功能垂体腺瘤中下调,但在生长激素腺瘤中不下调。
PLoS One. 2013 Oct 2;8(10):e77406. doi: 10.1371/journal.pone.0077406. eCollection 2013.
10
Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.生长抑素受体亚型sst1、sst2、sst3和sst5在人垂体、胃肠胰腺及乳腺肿瘤中的表达:mRNA分析与受体放射自显影的比较
Int J Cancer. 1997 Mar 4;70(5):530-7. doi: 10.1002/(sici)1097-0215(19970304)70:5<530::aid-ijc7>3.0.co;2-z.

引用本文的文献

1
The Evolving Landscape of GEP-NENs in the Era of Precision Oncology: Molecular Insights into Tumor Heterogeneity.精准肿瘤学时代GEP-NENs的演变格局:对肿瘤异质性的分子见解
Cancers (Basel). 2025 Jun 21;17(13):2080. doi: 10.3390/cancers17132080.
2
Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma.评估生长抑素/可体松系统在胶质母细胞瘤中的诊断、预后及治疗潜力。
Cell Mol Life Sci. 2025 Apr 23;82(1):173. doi: 10.1007/s00018-025-05687-9.
3
DNA Methylation in Pituitary Adenomas: A Scoping Review.

本文引用的文献

1
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.肿瘤耐药性:从细胞膜到细胞内信号转导。
Nat Rev Endocrinol. 2021 Sep;17(9):560-571. doi: 10.1038/s41574-021-00514-0. Epub 2021 Jun 30.
2
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression.胰腺神经内分泌肿瘤的表观遗传学景观揭示了不同的起源细胞和肿瘤进展的方式。
Commun Biol. 2020 Dec 7;3(1):740. doi: 10.1038/s42003-020-01479-y.
3
A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1.
垂体腺瘤中的DNA甲基化:一项范围综述
Int J Mol Sci. 2025 Jan 10;26(2):531. doi: 10.3390/ijms26020531.
4
Pituitary Adenoma: rs2236750, rs34037914, and rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations.垂体腺瘤:rs2236750、rs34037914 和 rs267606574 遗传变异、血清水平与 Ki-67 标记指数的相关性。
Medicina (Kaunas). 2024 Aug 1;60(8):1252. doi: 10.3390/medicina60081252.
5
The Role of Receptor-Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors.受体-配体相互作用在生长抑素信号通路中的作用:对神经内分泌肿瘤的影响
Cancers (Basel). 2023 Dec 25;16(1):116. doi: 10.3390/cancers16010116.
6
The role of DNA methylation in human pancreatic neuroendocrine tumours.DNA甲基化在人类胰腺神经内分泌肿瘤中的作用。
Endocr Oncol. 2023 Apr 17;3(1):e230003. doi: 10.1530/EO-23-0003. eCollection 2023 Jan 1.
7
Molecular targets in acromegaly.肢端肥大症的分子靶点。
Front Endocrinol (Lausanne). 2022 Dec 5;13:1068061. doi: 10.3389/fendo.2022.1068061. eCollection 2022.
8
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.RNA 生物学在神经内分泌肿瘤中的兴起:剪接改变和 RNA 种类揭示了翻译机会。
Rev Endocr Metab Disord. 2023 Apr;24(2):267-282. doi: 10.1007/s11154-022-09771-4. Epub 2022 Nov 24.
9
Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors.难治性胃肠胰神经内分泌肿瘤
Cancers (Basel). 2022 Sep 29;14(19):4769. doi: 10.3390/cancers14194769.
10
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤中的表观遗传调控
Front Oncol. 2022 Jun 7;12:901435. doi: 10.3389/fonc.2022.901435. eCollection 2022.
胰腺神经内分泌肿瘤细胞系BON-1和QGP-1的全面分子特征分析
Cancers (Basel). 2020 Mar 14;12(3):691. doi: 10.3390/cancers12030691.
4
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion.进化中的故事:清晰、连贯与磋商,而非矛盾与混乱。
Pituitary. 2020 Aug;23(4):476-477. doi: 10.1007/s11102-019-01027-w.
5
A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement.垂体腺瘤的故事:是神经内分泌肿瘤还是非神经内分泌肿瘤:垂体学会立场声明
Pituitary. 2019 Dec;22(6):569-573. doi: 10.1007/s11102-019-00988-2.
6
Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.USP8、HMGA和非编码RNA在垂体肿瘤发生中的新作用。
Cancers (Basel). 2019 Sep 4;11(9):1302. doi: 10.3390/cancers11091302.
7
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.剪接体复合物 SF3B1 作为前列腺癌的新型预后生物标志物和治疗靶点。
Transl Res. 2019 Oct;212:89-103. doi: 10.1016/j.trsl.2019.07.001. Epub 2019 Jul 9.
8
Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells.色氨酸羟化酶抑制剂替洛利司他对 2D 和 3D 培养胰腺神经内分泌肿瘤细胞生长和 5-羟色胺分泌的影响。
Neuroendocrinology. 2020;110(5):351-363. doi: 10.1159/000502200. Epub 2019 Jul 19.
9
Treatment Options for Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤的治疗选择
Cancers (Basel). 2019 Jun 14;11(6):828. doi: 10.3390/cancers11060828.
10
Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.异常甲基化介导的长链非编码 RNA SSTR5-AS1 下调促进喉鳞状细胞癌的进展和转移。
Epigenetics Chromatin. 2019 Jun 13;12(1):35. doi: 10.1186/s13072-019-0283-8.